leukotriene-b4 has been researched along with Cerebral-Hemorrhage* in 3 studies
1 review(s) available for leukotriene-b4 and Cerebral-Hemorrhage
Article | Year |
---|---|
[A Research on Drug Discovery for Intracerebral Hemorrhage Focusing on Leukotriene B
Intracerebral hemorrhage (ICH) results from blood vessels rupture in the brain, forming a blood clot in the brain parenchyma. Leakage of blood constituents causes detrimental tissue damages, ensuing long-lasting neurological deficits; however, effective therapeutic approaches are not yet developed to date. In this study, leukotriene B Topics: Administration, Oral; Animals; Brain; Cell Movement; Cerebral Hemorrhage; Disease Models, Animal; Drug Discovery; HL-60 Cells; Humans; Leukotriene B4; Mice; Microglia; Molecular Targeted Therapy; Neutrophil Infiltration; Phenylpropionates; Receptors, Leukotriene B4; Thrombin | 2020 |
2 other study(ies) available for leukotriene-b4 and Cerebral-Hemorrhage
Article | Year |
---|---|
Microglia-released leukotriene B
Intracerebral hemorrhage (ICH) from blood vessel rupture results in parenchymal hematoma formation and neuroinflammation, ultimately leading to neurodegeneration. Several lines of evidence suggest that the severity of ICH-induced neural damage is exacerbated by infiltration of T-cells, monocytes, and especially neutrophils into the hematoma. Neutrophil migration is regulated by chemokines, formyl peptides, and leukotriene B Topics: Animals; Brain; Cell Line; Cerebral Hemorrhage; Cytokines; Humans; Leukotriene B4; Male; Mice, Inbred C57BL; Microglia; Neutrophil Infiltration | 2020 |
Plasma levels of leukotriene C4, B4, slow reacting substance of anaphylaxis in chronological phases of cerebrovascular disease.
In this study we report and compare plasma leukotriene (LT) levels in seventeen (17) patients with cerebral infarction, five (5) patients with cerebral hemorrhage and twelve (12) age-matched healthy volunteers. Plasma samples were collected at intervals of 1-7 days, 8-14 days, 15-30 days and 31 days- after cerebrovascular accident. Plasma immunoreactive LTC4, LTB4 and SRS-A (Slow Reacting Substance of Anaphylaxis or total peptido-LT's) levels were measured for each sample. Immunoreactive LTC4 (and SRS-A) levels were elevated in patients with cerebral infarction whilst LTB4 levels were raised in the patients with cerebral hemorrhage. In particular, cerebral infarcted patients exhibited significantly elevated levels in phases 1-7 days and after 15 days when compared with the age-matched healthy volunteers. In patients with cerebral hemorrhage, significant increases in LTB4 were measured in days 1-7 only. These results suggest a clinical relationship between the plasma levels of LT's and cerebrovascular disease. Topics: Adult; Aged; Cerebral Hemorrhage; Cerebral Infarction; Chromatography, High Pressure Liquid; Female; Humans; Leukotriene B4; Male; Middle Aged; Radioimmunoassay; Reference Values; SRS-A; Time Factors | 1988 |